secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2026-06-10T21:28:24+00:00
Accession:  0001437749-26-020203
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key receives Nasdaq notice for delayed 10-Q filing; delisting hearing set for June 16
--------------------------------------------------------------------------------

- Received Nasdaq notice of non-compliance with Listing Rule 5250(c)(1) for failure to timely file Q1 2026 Form 10-Q.
- This is an additional basis for delisting; previously appealed Nasdaq's May 6 determination to suspend trading.
- Hearing before Nasdaq Hearing Panel scheduled for June 16, 2026.
- No assurance that the Panel will grant continued listing or that compliance can be regained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926020203/0001437749-26-020203-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774926020203/bkyi20260610_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-020203

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer